Your browser doesn't support javascript.
loading
Reply to Tran et al.: Dimeric KRAS protein-protein interaction stabilizers.
Kessler, Dirk; Gollner, Andreas; Gmachl, Michael; Mantoulidis, Andreas; Martin, Laetitia J; Zoephel, Andreas; Mayer, Moriz; Covini, David; Fischer, Silke; Gerstberger, Thomas; Gmaschitz, Teresa; Goodwin, Craig; Greb, Peter; Häring, Daniela; Hela, Wolfgang; Hoffmann, Johann; Karolyi-Oezguer, Jale; Knesl, Petr; Kornigg, Stefan; Koegl, Manfred; Kousek, Roland; Lamarre, Lyne; Moser, Franziska; Munico-Martinez, Silvia; Peinsipp, Christoph; Phan, Jason; Rinnenthal, Jörg; Sai, Jiqing; Salamon, Christian; Scherbantin, Yvonne; Schipany, Katharina; Schnitzer, Renate; Schrenk, Andreas; Sharps, Bernadette; Siszler, Gabriella; Sun, Qi; Waterson, Alex; Wolkerstorfer, Bernhard; Zeeb, Markus; Pearson, Mark; Fesik, Stephen W; McConnell, Darryl B.
Affiliation
  • Kessler D; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Gollner A; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Gmachl M; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Mantoulidis A; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Martin LJ; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Zoephel A; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Mayer M; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Covini D; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Fischer S; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Gerstberger T; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Gmaschitz T; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Goodwin C; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235.
  • Greb P; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Häring D; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Hela W; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Hoffmann J; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Karolyi-Oezguer J; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Knesl P; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Kornigg S; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Koegl M; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Kousek R; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Lamarre L; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Moser F; Discovery Research, Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach an der Riss, Germany.
  • Munico-Martinez S; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Peinsipp C; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Phan J; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235.
  • Rinnenthal J; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Sai J; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235.
  • Salamon C; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Scherbantin Y; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Schipany K; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Schnitzer R; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Schrenk A; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Sharps B; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Siszler G; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Sun Q; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235.
  • Waterson A; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37235.
  • Wolkerstorfer B; Department of Chemistry, Vanderbilt University, Nashville, TN 37235.
  • Zeeb M; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • Pearson M; Discovery Research, Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach an der Riss, Germany.
  • Fesik SW; Discovery Research, Boehringer Ingelheim RCV GmbH & Co KG, 1120 Vienna, Austria.
  • McConnell DB; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37235.
Proc Natl Acad Sci U S A ; 117(7): 3365-3367, 2020 02 18.
Article in En | MEDLINE | ID: mdl-32047042
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Document type: Article Affiliation country: